Valuation Poolbeg Pharma PLC

Equities

Market Closed - London S.E. Other stock markets 10:05:02 06/02/2026 pm IST			5-day change	1st Jan Change
4.600 ^GBX	+4.55%		+4.55%	+15.00%

26/12	Certain Ordinary Shares of Poolbeg Pharma PLC are subject to a Lock-Up Agreement Ending on 26-DEC-2025.	CI
08/12	Poolbeg Pharma plc Announces the POLB 001 Trial Is to Feature in Cancer Immunotherapy-Induced CRSResearch Programme	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026
Capitalization ¹	47.5	30.25	45.25	35.5	32.43	32.43
Change	-	-36.32%	49.59%	-21.55%	-8.63%	0%
Enterprise Value (EV) ¹	47.5	14.06	33.08	27.68	25.28	30.48
Change	-	-70.41%	135.32%	-16.33%	-8.64%	20.57%
P/E ratio	-12.8x	-6.44x	-11.5x	-6.12x	-4.65x	-5.54x
PBR	-	1.65x	3.02x	3.83x	3.83x	11.5x
PEG	-	-0.2x	0.7x	-0.1x	0.3x	0.3x
Capitalization / Revenue	-	-	-	-	-	-
EV / Revenue	-	-	-	-	-	-
EV / EBITDA	-	-2.83x	-7.1x	-4.61x	-4.68x	-5.44x
EV / EBIT	-	-2.82x	-7.06x	-4.53x	-4.36x	-5.17x
EV / FCF	-	-2.83x	-7.26x	-5.8x	-4.96x	-5.65x
FCF Yield	-	-35.3%	-13.8%	-17.3%	-20.2%	-17.7%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-0.0074	-0.0094	-0.0079	-0.0116	-0.0099	-0.0083
Distribution rate	-	-	-	-	-	-
Net sales ¹	-	-	-	-	-	-
EBITDA ¹	-	-4.96	-4.66	-5.997	-5.4	-5.6
EBIT ¹	-	-4.986	-4.686	-6.111	-5.8	-5.9
Net income ¹	-2.336	-4.686	-3.931	-5.79	-5.95	-5.75
Net Debt ¹	-	-16.19	-12.17	-7.824	-7.15	-1.95
Reference price ²	0.0950	0.0605	0.0905	0.0710	0.0460	0.0460
Nbr of stocks (in thousands)	5,00,000	5,00,000	5,00,000	5,00,000	7,05,104	7,05,104
Announcement Date	02/03/22	30/03/23	30/04/24	20/05/25	-	-

¹GBP in Million²GBP

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
POOLBEG PHARMA PLC	-4.65x	-	-4.68x	-	4.41Cr
ARGENX SE	46.3x	11.03x	39.37x	0.02%	5.03TCr
WUXI APPTEC CO., LTD.	16.91x	6.04x	13.29x	1.77%	4.21TCr
INSMED INCORPORATED	-25.72x	51.77x	-29.4x	-.--%	3.2TCr
BIONTECH SE	-26.38x	4.43x	-12.22x	-.--%	2.68TCr
WUXI BIOLOGICS (CAYMAN) INC.	30.86x	6.1x	16.89x	-.--%	2TCr
GENMAB A/S	16.61x	3.9x	10.31x	-.--%	1.91TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	-175.88x	43.39x	-175.79x	-.--%	1.26TCr
AKESO, INC.	-306.26x	24.05x	1011.94x	-.--%	1.19TCr
Average	-47.58x	18.84x	96.63x	0.22%	2.39TCr
Weighted average by Cap.	-15.92x	16.83x	54.13x	0.35%